Related references
Note: Only part of the references are listed.Immuno-potentiating pathway of HBsAg-HBIG immunogenic complex visualized
Hu Liu et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Relevance of serum interleukin-33 and ST2 levels and the natural course of chronic hepatitis B virus infection
Shu-Ling Huan et al.
BMC INFECTIOUS DISEASES (2016)
Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B
Anna S. Lok et al.
JOURNAL OF HEPATOLOGY (2016)
The role of innate immunity in the immunopathology and treatment of HBV infection
Mala K. Maini et al.
JOURNAL OF HEPATOLOGY (2016)
Specific CD8+ T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis
Elia Moreno-Cubero et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg plus Chronic Hepatitis B Infection
Mamun Al-Mahtab et al.
PLOS ONE (2016)
Immune therapy for hepatitis B
Sheikh Mohammad Fazle Akbar et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
Recognition of core-derived epitopes from a novel HBV-targeted immunotherapeutic by T-cells from patients infected by different viral genotypes
Ophelie Godon et al.
VACCINE (2015)
T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance
B. Ye et al.
CELL DEATH & DISEASE (2015)
γδT Cells Drive Myeloid-Derived Suppressor Cell-Mediated CD8+ T Cell Exhaustion in Hepatitis B Virus-Induced Immunotolerance
Xiaohui Kong et al.
JOURNAL OF IMMUNOLOGY (2014)
Vaccine therapies for chronic hepatitis B: can we go further?
Yumei Wen et al.
FRONTIERS OF MEDICINE (2014)
Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion
Dimitra Peppa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Reversal of hepatitis B virus-induced systemic immune tolerance by intrinsic innate immune stimulation
Qiuju Han et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: Experiences and findings
Dao-Zhen Xu et al.
JOURNAL OF HEPATOLOGY (2013)
Monoclonal antibody-based therapies in cancer: Advances and challenges
Puja Sapra et al.
PHARMACOLOGY & THERAPEUTICS (2013)
A pilot randomized controlled trial of dual-plasmid HBV DNA vaccine mediated by in vivo electroporation in chronic hepatitis B patients under lamivudine chemotherapy
F. -Q. Yang et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus
S. Chen et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
A Proinflammatory Role for Interleukin-22 in the Immune Response to Hepatitis B Virus
Ye Zhang et al.
GASTROENTEROLOGY (2011)
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges
Marie-Louise Michel et al.
JOURNAL OF HEPATOLOGY (2011)
Safety and immunogenicity of hepatitis B surface antigen-pulsed dendritic cells in patients with chronic hepatitis B
S. M. F. Akbar et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Immune and Viral Profile from Tolerance to Hepatitis B Surface Antigen Clearance: a Longitudinal Study of Vertically Hepatitis B Virus-Infected Children on Combined Therapy
Ivana Carey et al.
JOURNAL OF VIROLOGY (2011)
Autologus dendritic cell vaccine for chronic hepatitis B carriers: A pilot, open label, clinical trial in human volunteers
Jin Luo et al.
VACCINE (2010)
Blockade of Immunosuppressive Cytokines Restores NK Cell Antiviral Function in Chronic Hepatitis B Virus Infection
Dimitra Peppa et al.
PLOS PATHOGENS (2010)
Hepatitis B Virus Suppresses Toll-like Receptor-Mediated Innate Immune Responses in Murine Parenchymal and Nonparenchymal Liver Cells
Jun Wu et al.
HEPATOLOGY (2009)
A Randomized Controlled Phase IIb Trial of Antigen-Antibody Immunogenic Complex Therapeutic Vaccine in Chronic Hepatitis B Patients
Dao-Zhen Xu et al.
PLOS ONE (2008)
Therapeutic effect of hepatitis B surface antigen-antibody complex is associated with cytolytic and non-cytolytic immune responses in hepatitis B patients
Xin Yao et al.
VACCINE (2007)
Vaccination with recombinant HBsAg-HBIG complex in healthy adults
DZ Xu et al.
VACCINE (2005)
Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection
JN Stoop et al.
HEPATOLOGY (2005)
Selective functional deficit in dendritic cell - T cell interaction is a crucial mechanism in chronic hepatitis B virus infection
BJ Zheng et al.
JOURNAL OF VIRAL HEPATITIS (2004)
Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: Implications for immunotherapy of persistent viral infections
K Kakimi et al.
JOURNAL OF VIROLOGY (2002)
Therapeutic efficacy of hepatitis B surface antigen-antibodies-recombinant DNA composite in HBsAg transgenic mice
BJ Zheng et al.
VACCINE (2001)
Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future
ML Michel et al.
VACCINE (2001)
DNA vaccines for prophylactic or therapeutic immunization against hepatitis B
ML Michel et al.
INTERVIROLOGY (2001)
Viruses, immunity, and cancer: Lessons from hepatitis B
FV Chisari
AMERICAN JOURNAL OF PATHOLOGY (2000)
Break of T cell ignorance to a viral antigen in the liver induces hepatitis
D Voehringer et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
